Attached files

file filename
10-K - FORM 10-K - International Stem Cell CORPd10k.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - International Stem Cell CORPdex312.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - International Stem Cell CORPdex311.htm
EX-23.1 - CONSENT OF VASQUEZ & COMPANY LLP - International Stem Cell CORPdex231.htm
EX-10.19 - FORM OF STOCK OPTION AGREEMENT - International Stem Cell CORPdex1019.htm
EX-10.18 - EMPLOYMENT AGREEMENT - International Stem Cell CORPdex1018.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - International Stem Cell CORPdex322.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of International Stem Cell Corporation (the “Company”) on Form 10-K for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on March 23, 2010 (the “Report”), I, Andrey Semechkin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 23, 2010

 

/s/ Andrey Semechkin

Andrey Semechkin

Chief Executive Officer

(Principal Executive Officer)